pharmacie et médicaments – Accès aux traitements innovants contre la maladie d'Alzheimer

This written question concerns access to innovative treatments for Alzheimer's disease. It seeks to understand the conditions and challenges related to making these new therapies available to patients. The question addresses the pharmaceutical industry, healthcare providers, and patients suffering from Alzheimer's. It aims to ensure timely and equitable access to cutting-edge treatments.